China’s securities regulator has signed off on Unitree Robotics’ registration to list on Shanghai’s STAR Market. The early-July approval removes a major procedural obstacle for the Hangzhou robot maker, though pricing, subscription and trading dates are still unconfirmed.
The Hangzhou-based company, one of China’s most visible humanoid and quadruped robot makers, proposes raising about RMB4.2 billion in the offering. Proceeds would fund robot AI model research, robot-body development, new product lines and a smart-robot manufacturing base.
Unitree has become a global name in embodied AI, selling robots to researchers, developers and companies experimenting with physical AI systems. Its machines have appeared in everything from factory trials to viral videos, and the company is frequently cited alongside Chinese rivals like UBTech as the country races to lead in humanoid robotics.
The registration approval comes after China’s top court separately found patent lawsuits against Unitree to be malicious, clearing another distraction from its path to market. The company’s timetable for a final listing remains unconfirmed in official documents, but the regulatory green light removes one of the biggest remaining obstacles.
An IPO would give Unitree a deep pool of public capital to fight for share in a humanoid robot market that Beijing has singled out as strategic. Analysts expect Chinese robot makers to lean on public markets as global competition with Tesla’s Optimus and other Western efforts intensifies.
